---
title: "Stocks in Play: DRI Healthcare Trust"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291158798.md"
description: "10:07 AM EST - DRI Healthcare Trust : DRI Healthcare Trust (TSX: DHT.UN) today commented on Viridian Therapeutics, Inc.'s recently announced approval by the U.S. Food and Drug Administration of Lumvoa™ (veligrotug-vvze) for the treatment of thyroid eye disease. TED is an autoimmune inflammatory disorder of the orbit (eye socket) that affects numerous patients in the U.S. and can cause debilitating and disfiguring eye symptoms (e.g., inflammation, proptosis, and double-vision) with severe disease leading to vision loss. DRI Healthcare Trust shares T.DHT.UN are trading up $0.66 at $18.11."
datetime: "2026-06-29T14:10:44.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291158798.md)
  - [en](https://longbridge.com/en/news/291158798.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291158798.md)
---

# Stocks in Play: DRI Healthcare Trust

**10:07 AM EST - DRI Healthcare Trust :** DRI Healthcare Trust (TSX: DHT.UN) today commented on Viridian Therapeutics, Inc.'s recently announced approval by the U.S. Food and Drug Administration of Lumvoa™ (veligrotug-vvze) for the treatment of thyroid eye disease. TED is an autoimmune inflammatory disorder of the orbit (eye socket) that affects numerous patients in the U.S. and can cause debilitating and disfiguring eye symptoms (e.g., inflammation, proptosis, and double-vision) with severe disease leading to vision loss. DRI Healthcare Trust shares T.DHT.UN are trading **up $0.66** at $18.11.

### Related Stocks

- [VRDN.US](https://longbridge.com/en/quote/VRDN.US.md)

## Related News & Research

- [12:25 ETRaymond Douglas, MD, PhD, Is First in the Nation to Infuse Newly FDA-Approved Thyroid Eye Disease Treatment, LUMVOA ™ (veligrotug-vvze)](https://longbridge.com/en/news/292931199.md)
- [VRDN: FDA approves Lumvoa for TED, offering rapid, durable relief and broad patient access](https://longbridge.com/en/news/291165211.md)
- [CIBC Remains a Buy on DRI Healthcare (DHT.UN)](https://longbridge.com/en/news/294405595.md)
- [DHT Holdings (DHT) Could Be 49% Undervalued On Fleet Renewal Completion](https://longbridge.com/en/news/293806373.md)
- [DHT Holdings Completes 2026 VLCC Fleet Renewal Milestones](https://longbridge.com/en/news/293932386.md)